Format

Send to

Choose Destination
J Antibiot (Tokyo). 1988 Dec;41(12):1745-51.

Lysobactin, a novel antibacterial agent produced by Lysobacter sp. II. Biological properties.

Author information

1
Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000.

Abstract

Lysobactin, an antibiotic isolated from a strain of Lysobacter, is 2 to 4-fold more active than vancomycin against aerobic and anaerobic Gram-positive bacteria. Included in the spectrum of lysobactin are Staphylococci, Streptococci, corynebacteria, clostridia and various other Gram-positive anaerobic bacteria. The activity of lysobactin against aerobic and anaerobic Gram-negative bacteria is poor. When given parenterally the compound was efficacious in systemic staphylococcal and streptococcal infections in mice. Similarly, when applied topically lysobactin was also curative in a staphylococcal wound infection in mice. Some studies on the mode of action of lysobactin are presented.

PMID:
3209466
DOI:
10.7164/antibiotics.41.1745
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for J-STAGE, Japan Science and Technology Information Aggregator, Electronic
Loading ...
Support Center